Groundbreaking Covid-19 trials a boost, not bogeyman, for Africa
The trials mean SA will have access to vaccines, which is important in the face of ‘vaccine nationalism’, say experts
If SA is a place of contradictions, this week has been the perfect illustration.
We crossed the threshold to 100,000 confirmed cases of Covid-19 early in the week and hot on those heels came the announcement by Johannesburg’s Wits University that the continent’s first vaccine trial, for the same disease, kicks off.
On Wednesday, the first participants from Africa will be vaccinated in a local trial, carried out by Wits and the UK’s Oxford University. It forms part of a global search for a prevention against Covid-19...